Citigroup Assigned “a Buy” Rating to Evolent Health Inc (NYSE:EVH) Stock

Citigroup raised the price target for the Evolent Health Inc (NYSE:EVH) stock to “a Buy”. The rating was released on April 22, 2024, according to finviz. The research report from Barclays has initiated the stock to Overweight, with a price target set at $39. The stock was initiated by JMP Securities, who disclosed in a […]

Bowlero Corp (NYSE:BOWL) stock is trading 60.00 percent above its 52-week low

B. Riley Securities raised the price target for the Bowlero Corp (NYSE:BOWL) stock to “a Buy”. The rating was released on June 02, 2023, according to finviz. The research report from Stifel has initiated the stock to Buy, with a price target set at $26. The stock was initiated by Canaccord Genuity, who disclosed in […]

Pagerduty Inc (NYSE:PD) Stock is trading Above 5.99% From 50-Day SMA

Craig Hallum raised the price target for the Pagerduty Inc (NYSE:PD) stock from “a Hold” to “a Buy”. The rating was released on June 12, 2024, according to finviz. We previously noted in another research note published on March 18, 2024 by Truist that upgraded the stock from a Hold to a Buy with a […]

Magnite Inc (NASDAQ:MGNI) Stock higher 41.22% in This Year: What’s Happened?

BofA Securities raised the price target for the Magnite Inc (NASDAQ:MGNI) stock from “a Neutral” to “a Buy”. The rating was released on May 24, 2024, according to finviz. The research report from BofA Securities has initiated the stock to Neutral, with a price target set at $11. The stock was upgraded by Evercore ISI, […]

Why Axsome Therapeutics Inc (NASDAQ:AXSM) Stock rose 11.27% in Last Six Months?

Morgan Stanley raised the price target for the Axsome Therapeutics Inc (NASDAQ:AXSM) stock from “an Equal-weight” to “an Overweight”. The rating was released on April 29, 2024, according to finviz. The research report from UBS has initiated the stock to Buy, with a price target set at $111. The stock was initiated by RBC Capital […]

Why RxSight Inc (NASDAQ:RXST) Stock climbed 14.85% in Last Three Months?

BTIG Research raised the price target for the RxSight Inc (NASDAQ:RXST) stock to “a Buy”. The rating was released on May 07, 2024, according to finviz. We previously noted in another research note published on December 13, 2023 by Wells Fargo that upgraded the stock from an Equal weight to an Overweight with a price […]